Results 1 to 10 of about 12,044 (250)
Ocular myasthenia gravis management [PDF]
Frontiers in NeurologyOcular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite
Mark J. Kupersmith +2 more
doaj +4 more sources
Neurologijos seminarai, 2022 Myasthenia gravis is a chronic autoimmune neuromuscular disorder typically presenting with variable skeletal muscle fatigue. The most prevalent initial manifestation of myasthenia is ocular myasthenia.
J. Zakaravičiūtė, M. Šerelytė
doaj +4 more sources
Off-center presentation of ocular myasthenia
Kerala Journal of Ophthalmology, 2022 Myasthenia gravis is an autoimmune condition with varied presentations. In this, we report a 70 years old diabetic male who came complaining of diplopia.
Mary A Stephen +2 more
doaj +2 more sources
The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis [PDF]
Journal of Ophthalmology, 2014 Aim. To estimate the clinical significance of anti-acetylcholine receptor antibody (anti-AChR-Ab) levels in suspected ocular myasthenia gravis. Methods. In total, 144 patients complaining of fluctuating diplopia and ptosis were evaluated for serum levels
Jung Jin Lee +2 more
doaj +2 more sources
Indian Journal of Ophthalmology, 2022 Purpose: To assess the diagnostic accuracy of forced eyelid closure test (FECT), ice pack test (IPT), repetitive nerve stimulation test (RNS), and acetylcholine receptor (AchR) antibody test in patients with suspected ocular myasthenia.
PriyaSivakumar +2 more
doaj +2 more sources
Ocular myasthenia gravis in a setting of thyrotoxicosis
Indian Journal of Endocrinology and Metabolism, 2013 Ocular myasthenia gravis in conjunction with thyroid disorders, although rare, has been reported in the past. However, the similarity in the presentation of both the entities and the tendency of myasthenia gravis to get overlooked easily, even by ...
Sarabjeet Chhabra, B C Pruthvi
doaj +2 more sources
Ocular myasthenia gravis [PDF]
Russian Annals of OphthalmologyMyasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as ...
M.S. Sergeeva +2 more
+5 more sources
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis [PDF]
American Journal of Perinatology Reports, 2016 Background Myasthenia gravis (MG) is an autoimmune disorder with fluctuating muscle weakness, divided into generalized and localized (ocular) forms.
Courtney Townsel +4 more
doaj +2 more sources
Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis [PDF]
European Journal of Case Reports in Internal Medicine, 2017 Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscle fatiguability and weakness. The pathological characteristics of the disorder include ocular weakness resulting in diplopia and/or ptosis.
Moneeb Sefeldawla Mustafa +3 more
doaj +4 more sources
Add‐On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real‐World Case Series [PDF]
Brain and BehaviorIntroduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional immunotherapies often prove ineffective.
Jing Lin +4 more
doaj +2 more sources